Cargando…
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
OBJECTIVE: To evaluate the effect of postoperative pathological findings related to the eligibility of adjuvant immunotherapy on oncologic outcomes in patients with localized and locally advanced muscle‐invasive bladder carcinoma (MIBC) and upper tract urothelial carcinoma (UTUC). PATIENTS AND METHO...
Autores principales: | Miura, Yuki, Hatakeyama, Shingo, Tanaka, Toshikazu, Fujita, Naoki, Horiguchi, Hirotaka, Okuyama, Yoshiharu, Kojima, Yuta, Noro, Daisuke, Tokui, Noriko, Okamoto, Teppei, Yamamoto, Hayato, Ito, Hiroyuki, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988644/ https://www.ncbi.nlm.nih.gov/pubmed/35474729 http://dx.doi.org/10.1002/bco2.117 |
Ejemplares similares
-
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021) -
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021) -
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021) -
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
por: Togashi, Kyo, et al.
Publicado: (2022) -
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)